← Evidence map

ArticleACS pharmacology & translational science2023

Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment.

Jinhua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37588758